Addus HomeCare (ADUS) Competitors

Guardant Health (NASDAQ:GH) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment, community ranking and earnings.

Which has more risk and volatility, GH or ADUS?

Guardant Health has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Which has higher earnings and valuation, GH or ADUS?

Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$563.95M	9.39	-$479.45M	-$4.24	-10.11
Addus HomeCare	$1.06B	1.87	$62.52M	$4.37	25.00

Do insiders and institutionals hold more shares of GH or ADUS?

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are held by institutional investors. 5.5% of Guardant Health shares are held by insiders. Comparatively, 4.6% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Is GH or ADUS more profitable?

Addus HomeCare has a net margin of 6.50% compared to Guardant Health's net margin of -74.02%. Addus HomeCare's return on equity of 9.62% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-74.02%	-1,200.44%	-29.88%
Addus HomeCare	6.50%	9.62%	7.37%

Does the media prefer GH or ADUS?

In the previous week, Guardant Health had 14 more articles in the media than Addus HomeCare. MarketBeat recorded 21 mentions for Guardant Health and 7 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.19 beat Guardant Health's score of 0.54 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Addus HomeCare	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer GH or ADUS?

Guardant Health presently has a consensus price target of $44.78, suggesting a potential upside of 4.45%. Addus HomeCare has a consensus price target of $134.22, suggesting a potential upside of 22.88%. Given Addus HomeCare's higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	0 Strong Buy rating(s)	3.00
Addus HomeCare	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer GH or ADUS?

Addus HomeCare received 38 more outperform votes than Guardant Health when rated by MarketBeat users. However, 70.59% of users gave Guardant Health an outperform vote while only 68.78% of users gave Addus HomeCare an outperform vote.

Company	Underperform	Outperform
Guardant Health	Outperform Votes 288 70.59%	Underperform Votes 120 29.41%
Addus HomeCare	Outperform Votes 326 68.78%	Underperform Votes 148 31.22%

Summary

Addus HomeCare beats Guardant Health on 12 of the 18 factors compared between the two stocks.